Cancer Care Northwest CC Northwest- Spokane South(3) — Spokane, Washington

Cancer Care Northwest CC Northwest- Spokane South(3) is a clinical research site located in Spokane, Washington, United States 99202.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Cancer Care Northwest CC Northwest- Spokane South(3) has participated in 2 clinical trials.

Therapeutic areas: Lymphoma, Mantle- Cell, Advanced Endometrial Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Care Northwest CC Northwest- Spokane South(3)?

Cancer Care Northwest CC Northwest- Spokane South(3) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Care Northwest CC Northwest- Spokane South(3) conducted?

Cancer Care Northwest CC Northwest- Spokane South(3) has 2 clinical trials on record. Their work covers Lymphoma, Mantle- Cell, Advanced Endometrial Cancer.

Is Cancer Care Northwest CC Northwest- Spokane South(3) accredited by Crixeo Health?

Cancer Care Northwest CC Northwest- Spokane South(3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Care Northwest CC Northwest- Spokane South(3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.